Practice parameters: initial therapy of Parkinson's disease (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology.
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*
D000978:Antiparkinson Agents